Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan wins final FDA approval for generic Prilosec capsules
Omeprazole delayed-release (DR) capsules are indicated for the treatment of peptic ulcers and gastroesophageal reflux disease. Mylan Pharmaceuticals is shipping this product immediately.
Omeprazole delayed-release (DR) capsules are indicated for the treatment of peptic ulcers and gastroesophageal reflux disease. Mylan Pharmaceuticals is shipping this product immediately.
Mr Perez is currently the executive vice president and COO at Cubist Pharmaceuticals, and is responsible for commercial operations, business development, technical operations, the Cubicin development team and
The Selexys Pharmaceutical project is to be executed in Cytovance’s multi-product process development and cGMP production facility in Oklahoma City over the next 15 months. The 44,000sqft facility
Most recently, Mr Renfro was one of Fidelity Investments’s most senior executive officers and a member of the Fidelity executive committee, overseeing several of Fidelity’s non-investment business units.
According to the company, the Press-Fit Total Hip system is a new hip implant system that incorporates a dual taper design. The initial regional release will follow with
Scytera foam is said to be the first coal tar product in an aerosol foam vehicle to be launched into the psoriasis market. Studies have demonstrated that coal
Net income and diluted earnings per share for the 2008 full year were $4.41 billion and $3.27, respectively, compared with $4.61 billion and $3.38, respectively, for the 2007
According to the company, dronedarone showed a decrease of safety events versus amiodarone but more occurrences of the composite primary endpoint. There were 184 patients (73.9%) who reached
The acquisition includes analytically validated, ultra-sensitive and ultra-specific tests for detection and monitoring of human papillomavirus (HPV), systemic lupus erythematosus, chronic kidney disease, inflammatory bowel disease, as well
Before joining Sequenom, Dr Bombard was the CEO of Lenetix Medical Laboratory of Mineola, New York. Prior to joining Lenetix, Dr Bombard was chief medical officer of Sharp